Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2016 Issue 7
2015 nian mei guo fda pi zhun de xin yao
shi zuo zuo ; feng yu fei ;
..............page:721-724
Pharmacological and clinical evaluation of lenvatinib
XU Jia-yin;ZHENG Jian-hong;Department of Pharmacy;First Affiliated Hospital of Xiamen University;
..............page:725-727
Analysis of the efficiency of technological innovation of Chinese pharmaceutical manufacturing industry based on DEA Malmquist index
HUO Yan-fei;SHI Sheng-yi;WANG Guang-ping;CHEN Ying;YI Ba-xian;China State Institute of Pharmaceutical Industry;China National Pharmaceutical Group Corporation;Shanghai Institute for Food and Drug Safety;
..............page:728-732+744
The quality risk and R&D of solid-liquid dual-chamber bag products
JIANG Yu;HUANG Xiao-long;Center for Drug Evaluation;China Food and Drug Administration;
..............page:733-738
Preparation and immunogenicity study of the Haemophilus influenzae type b conjugate vaccine based on a novel carrier protein
MIAO Dan-qing;LI Jun-qiang;YANG Ming-ming;SHAO Zhong-qi;ZHU Tao;Tianjin University of Science and Technology;Tianjin Can Sino Biotechnology Inc.;
..............page:739-744
The separation of exenatide acylation product from PLGA micropheres and its activity study
ZHANG Xue;LIANG Rong-cai;SUN Kao-xiang;LIU Wan-hui;WANG Ai-ping;FU Feng-hua;School of Pharmacy;Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong;Key Laboratory of Molecular Pharmacology and Drug Evaluation;Ministry of Education;Yantai University;State Key Laboratory of Long-Acting and Targeting Drug Delivery System;
..............page:745-750+759
Characteristics of drug metabolic enzymes
YANG Ran;MA Xiao-hui;GUO Jia-hua;LIU Wen-yuan;Department of Pharmaceutical Analysis;China Pharmaceutical University;Tasly Pharmaceutical Group Co.;Ltd.;Institute of Pharmacology and Toxicology Research Institute;
..............page:751-759
Advance in studies on the antitumor effects of wogonin and its derivatives and the underlying mechanisms
ZHAO Tian-he;ZHANG Ying-ying;WU Yang-yang;CHEN Bo;PENG Di;LIU Xiao-heng;ZENG Ye;Institute of Biomedical Engineering;School of Preclinical and Forensic Medicine;Sichuan University;West China School of Public Health;Sichuan University;West China School of Clinical Medicine;Sichuan University;
..............page:760-766
The research progress of TKI discontinuation in chronic myeloid leukemia
DONG Ying;ZHAO Yan-hong;SUN Jing;HAN Li-na;Hematology in First Affiliated Hosptial of Harbin Medical University;
..............page:767-770
Interpretation of “Bulletin on the Key Points of On-site Drug Clinical Trial Date Inspection Released by China Food and Drug Administration”
PENG Peng;YUAN Wei-an;HU Yi-hui;TANG Jie;ZHU Lei-lei;JIANG Jian;National Drug Clinical Trial Institution;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
..............page:771-774
ARO-CRO operation management mode of TCM clinical research
LI Rui;TANG Xu-dong;LU Fang;ZHAO Ying-pan;LI Bo;LI Qing-na;ZI Ming-jie;GAO Rui;Xiyuan Hospital of China Academy of Chinese Medical Sciences;Institution of Clinical Pharmacology;
..............page:775-778+786
Efficacy and tolerability of domestic blonanserin tablets in acute schizophrenic: a randomized,double-blind,risperidone-controlled trial
LIU Qi;ZHANG Hong-yan;CAO Qing-jiu;SHUANG Mei;YANG Fu-de;WANG Chuan-yue;SUN Ling;LI Yu-xin;DENG He-huang;ZHANG Xia;KANG Chuan-yuan;WANG Qiang;XIA Jie-lai;Peking University Sixth Hospital;Peking University Institute of Mental Health;Key Laboratory of Mental Health;Ministry of Health;Beijing Huilongguan Hospital;Beijing Anding Hospital of Capital Medical University;Tianjin Anding Hospital;Hebei Mental Health Center;Guangzhou Psychiatric Hospital;Wuxi Mental Health Center;First Affiliated Hospital;Kunming Medical Collage;West China Hospital of Sichuan University;Medical Statistics Department;the Fourth Military Medical University;
..............page:779-786
In vitro and in vivo liver cell micronucleus tests
WEN Hai-ruo;SONG Jie;CHEN Gao-feng;QI Nai-song;LI Chen;GENG Xing-chao;WANG Xue;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs;
..............page:787-793
The effect of atorvastatin on the expression of PTEN in aldosterone-induced cardiac fibroblasts
SUN Qian;LIU Xiu-ju;ZHAO Yu-han;Department of Pharmacy;The Second Hospital of Hebei Medical University;
..............page:794-797+803
Synthesis and antitumor activities of novel adamantly nitroxide derivatives for human hepatocellular carcinoma
SUN Jin;WANG Shan;MA Zhong-ying;LI Hui-hui;HU Na-ping;BU Wei;YAO Min-na;ZHANG En-hu;YANG Guo-dong;ZHU Xiao-he;Shaanxi University of Chinese Medicine;Department of Pharmacy;Xijing Hospital of the Fourth Military Medical University of PLA;State Key Laboratory of Cancer Biology;Department of Biochemistry and Molecular Biology;Fourth Military Medical University;
..............page:798-803
Synthesis of tafluprost
ZHU Jun;YANG Lu;WANG Yu-jun;ZHANG Li;The Research Institute of Northeast Pharmaceutical Group;
..............page:804-806
Optimized preparation of gefitinib chitosan protamine nanoparticles by central composite design-response surface method
WANG Zi-chen;ZHAO Wen-ming;College of Pharmacy;Jinzhou Medical University;
..............page:807-812+822
Absorption characteristics of vitamin E nanoemulsion in rat perfused intestine
GONG Yin-hua;GU Bao-chen;Department of Pharmacy;the First Hospital of Soochow University;
..............page:813-817
Preparation of glycyrrhetinic acid-loaded microparticles with homogeneous size and shape by hydrogel template method
WANG Hong;MA Yu-hua;WANG Wen-ping;School of Pharmacy;Ningxia Medical University;School of Pharmacy;Qinghai University for Nationalities;Key Lab of Hui Ethnic Medicine Modernization;Ministry of Education;Ningxia Engineering & Technology Research Center For Modernization of Hui Medicine;
..............page:818-822
Preparation for bi-layer osmotic pump tablets of felodipine solubilized by SBA-15
QIU Yang;WU Chao;ZHAO Zong-zhe;ZHAO Ying;HAO Yan-na;XU Jie;YU Tong;JI Peng;JIANG Jie;Liaoning Medical University;
..............page:823-829
Properties and dissolution in vitro of indomethacin Soluplus amorphous preparation
ZHANG Yi-zhuo;YAO Jing;YIN Dong-dong;SHI Nian-qiu;WANG Xing-lin;Pharmaceutical College of Henan University;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;Tianjin Institute of Pharmaceutical Research Company Limited;
..............page:830-835
Drug interaction between omeprazole and methotrexate:a case report and a review of the literature
YUAN Zheng;XU Jing;QIU Jin-chun;Zhengzhou Maternity and Child Health Hospital;Nanjing Children’s Hospital Affiliated to Nanjing Medical University;
..............page:836-840+835